Top Stories

Drugmakers pledge to prioritize safety; WHO says ‘this will not be the last pandemic’


Nine drugmakers working on coronavirus vaccines publicly pledged on Tuesday to prioritize safety and uphold rigorous scientific standards as concerns mount of political pressure to bring a vaccine to market before the Nov. 3 U.S. presidential election. The pledge sought to “ensure public confidence” by committing to only apply for regulatory authorization when enough data has been collected from a large phase three trial. Three vaccine manufacturers have now entered phase three trials. 

The following data was compiled by Johns Hopkins University:

  • Global cases: More than 27.3 million
  • Global deaths: At least 893,00
  • U.S. cases: More than 6.3 million
  • U.S. deaths: At least 189,200


Singapore investment company Temasek releases annual report 2020

Previous article

The Trump administration wants to discourage your 401(k) from including ESG investment options

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories